Cargando…

Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial

BACKGROUND: Hemoglobin measurement is important for transfusion decision-making. Pulse CO-Oximetry provides real-time continuous hemoglobin (SpHb) monitoring. The triage role of SpHb trends based on hemoglobin measurements was investigated. METHODS: In this diagnostic randomized controlled trial, 69...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bo, Yu, Xuerong, Xu, Li, Zhu, Afang, Zhang, Yuelun, Huang, Yuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525351/
https://www.ncbi.nlm.nih.gov/pubmed/31101083
http://dx.doi.org/10.1186/s12871-019-0755-1
_version_ 1783419709168812032
author Tang, Bo
Yu, Xuerong
Xu, Li
Zhu, Afang
Zhang, Yuelun
Huang, Yuguang
author_facet Tang, Bo
Yu, Xuerong
Xu, Li
Zhu, Afang
Zhang, Yuelun
Huang, Yuguang
author_sort Tang, Bo
collection PubMed
description BACKGROUND: Hemoglobin measurement is important for transfusion decision-making. Pulse CO-Oximetry provides real-time continuous hemoglobin (SpHb) monitoring. The triage role of SpHb trends based on hemoglobin measurements was investigated. METHODS: In this diagnostic randomized controlled trial, 69 patients undergoing spine or cytoreductive surgery were randomly enrolled into SpHb-monitoring and standard-care groups. Diagnostic blood samples were drawn for CO-oximetry Hb (CoOxHb) when the SpHb decreased by 1 g/dl or at the clinician’s discretion in the standard-care group. The positive predictive value (PPV) was defined as the ability to detect a decrease in CoOxHb > 1 g/dl or a CoOxHb < 10 g/dl; the PPVs were compared using Fisher’s exact test. The SpHb and trend accuracies were calculated. The transfusion units and postoperative hemoglobin levels were compared. RESULTS: The PPV of a decrease in CoOxHb > 1 g/dl was 93.3% in the SpHb group vs 54.5% without SpHb monitoring (p = 0.002). The PPV of CoOxHb < 10 g/dl was 86.7% vs. 50.0% for these groups (p = 0.015). The CoOxHb was never < 7 g/dl with SpHb monitoring. Sixty SpHb–CoOxHb data pairs and 28 delta pairs (ΔSpHb-ΔCoOxHb) were collected. The bias, precision and limits of agreement were − 0.29, 1.03 and − 2.30 to 1.72 g/dl, respectively. When ΔSpHb and ΔCoOxHb were > 1 g/dl, the concordance rate for changes in hemoglobin reached 100%. The delta pairs revealed a positive correlation [ΔSpHb = 0.49 * ΔCoOxHb - 0.13; r = 0.69, 95% confidence interval (0.53, 0.82)]. No significant differences were found in the transfusion volume or postoperative anemia state. CONCLUSIONS: The SpHb trend tracked changes in hemoglobin satisfactorily during surgery and more accurately estimated the appropriate timing for invasive hemoglobin measurements than the clinicians. TRIAL REGISTRATION: ChiCTR1800016290 (Prospective registered). Initial registration date was 24/05/2018.
format Online
Article
Text
id pubmed-6525351
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65253512019-05-24 Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial Tang, Bo Yu, Xuerong Xu, Li Zhu, Afang Zhang, Yuelun Huang, Yuguang BMC Anesthesiol Research Article BACKGROUND: Hemoglobin measurement is important for transfusion decision-making. Pulse CO-Oximetry provides real-time continuous hemoglobin (SpHb) monitoring. The triage role of SpHb trends based on hemoglobin measurements was investigated. METHODS: In this diagnostic randomized controlled trial, 69 patients undergoing spine or cytoreductive surgery were randomly enrolled into SpHb-monitoring and standard-care groups. Diagnostic blood samples were drawn for CO-oximetry Hb (CoOxHb) when the SpHb decreased by 1 g/dl or at the clinician’s discretion in the standard-care group. The positive predictive value (PPV) was defined as the ability to detect a decrease in CoOxHb > 1 g/dl or a CoOxHb < 10 g/dl; the PPVs were compared using Fisher’s exact test. The SpHb and trend accuracies were calculated. The transfusion units and postoperative hemoglobin levels were compared. RESULTS: The PPV of a decrease in CoOxHb > 1 g/dl was 93.3% in the SpHb group vs 54.5% without SpHb monitoring (p = 0.002). The PPV of CoOxHb < 10 g/dl was 86.7% vs. 50.0% for these groups (p = 0.015). The CoOxHb was never < 7 g/dl with SpHb monitoring. Sixty SpHb–CoOxHb data pairs and 28 delta pairs (ΔSpHb-ΔCoOxHb) were collected. The bias, precision and limits of agreement were − 0.29, 1.03 and − 2.30 to 1.72 g/dl, respectively. When ΔSpHb and ΔCoOxHb were > 1 g/dl, the concordance rate for changes in hemoglobin reached 100%. The delta pairs revealed a positive correlation [ΔSpHb = 0.49 * ΔCoOxHb - 0.13; r = 0.69, 95% confidence interval (0.53, 0.82)]. No significant differences were found in the transfusion volume or postoperative anemia state. CONCLUSIONS: The SpHb trend tracked changes in hemoglobin satisfactorily during surgery and more accurately estimated the appropriate timing for invasive hemoglobin measurements than the clinicians. TRIAL REGISTRATION: ChiCTR1800016290 (Prospective registered). Initial registration date was 24/05/2018. BioMed Central 2019-05-17 /pmc/articles/PMC6525351/ /pubmed/31101083 http://dx.doi.org/10.1186/s12871-019-0755-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tang, Bo
Yu, Xuerong
Xu, Li
Zhu, Afang
Zhang, Yuelun
Huang, Yuguang
Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
title Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
title_full Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
title_fullStr Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
title_full_unstemmed Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
title_short Continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
title_sort continuous noninvasive hemoglobin monitoring estimates timing for detecting anemia better than clinicians: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525351/
https://www.ncbi.nlm.nih.gov/pubmed/31101083
http://dx.doi.org/10.1186/s12871-019-0755-1
work_keys_str_mv AT tangbo continuousnoninvasivehemoglobinmonitoringestimatestimingfordetectinganemiabetterthancliniciansarandomizedcontrolledtrial
AT yuxuerong continuousnoninvasivehemoglobinmonitoringestimatestimingfordetectinganemiabetterthancliniciansarandomizedcontrolledtrial
AT xuli continuousnoninvasivehemoglobinmonitoringestimatestimingfordetectinganemiabetterthancliniciansarandomizedcontrolledtrial
AT zhuafang continuousnoninvasivehemoglobinmonitoringestimatestimingfordetectinganemiabetterthancliniciansarandomizedcontrolledtrial
AT zhangyuelun continuousnoninvasivehemoglobinmonitoringestimatestimingfordetectinganemiabetterthancliniciansarandomizedcontrolledtrial
AT huangyuguang continuousnoninvasivehemoglobinmonitoringestimatestimingfordetectinganemiabetterthancliniciansarandomizedcontrolledtrial